These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 22174762)
1. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762 [TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of CD105 expression during tumor angiogenesis. Hong H; Yang Y; Zhang Y; Engle JW; Barnhart TE; Nickles RJ; Leigh BR; Cai W Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1335-43. PubMed ID: 21373764 [TBL] [Abstract][Full Text] [Related]
3. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment. Zhang Y; Hong H; Orbay H; Valdovinos HF; Nayak TR; Theuer CP; Barnhart TE; Cai W Eur J Nucl Med Mol Imaging; 2013 May; 40(5):759-67. PubMed ID: 23344138 [TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment. Shi S; Orbay H; Yang Y; Graves SA; Nayak TR; Hong H; Hernandez R; Luo H; Goel S; Theuer CP; Nickles RJ; Cai W J Nucl Med; 2015 Jun; 56(6):927-32. PubMed ID: 25883125 [TBL] [Abstract][Full Text] [Related]
5. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence. Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. Zhang Y; Hong H; Engle JW; Yang Y; Theuer CP; Barnhart TE; Cai W Mol Pharm; 2012 Mar; 9(3):645-53. PubMed ID: 22292418 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment. Hong H; Zhang Y; Orbay H; Valdovinos HF; Nayak TR; Bean J; Theuer CP; Barnhart TE; Cai W Mol Pharm; 2013 Feb; 10(2):709-16. PubMed ID: 23316869 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753 [TBL] [Abstract][Full Text] [Related]
9. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Dearling JL; Voss SD; Dunning P; Snay E; Fahey F; Smith SV; Huston JS; Meares CF; Treves ST; Packard AB Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. Engle JW; Hong H; Zhang Y; Valdovinos HF; Myklejord DV; Barnhart TE; Theuer CP; Nickles RJ; Cai W Mol Pharm; 2012 May; 9(5):1441-8. PubMed ID: 22519890 [TBL] [Abstract][Full Text] [Related]
11. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Hong H; Zhang Y; Engle JW; Nayak TR; Theuer CP; Nickles RJ; Barnhart TE; Cai W Biomaterials; 2012 Jun; 33(16):4147-56. PubMed ID: 22386918 [TBL] [Abstract][Full Text] [Related]
12. TE1PA as Innovating Chelator for Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357 [TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice. Aghevlian S; Wu B; Raie MN; Tumbale SK; Kare AJ; Seo JW; Ferrara KW Nucl Med Biol; 2021; 98-99():8-17. PubMed ID: 33962357 [TBL] [Abstract][Full Text] [Related]
14. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates. Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653 [TBL] [Abstract][Full Text] [Related]
15. 64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics. Yang CT; Kim YS; Wang J; Wang L; Shi J; Li ZB; Chen X; Fan M; Li JJ; Liu S Bioconjug Chem; 2008 Oct; 19(10):2008-22. PubMed ID: 18763821 [TBL] [Abstract][Full Text] [Related]